Intersect ENT Inc is a commercial stage drug-device company engaged in improving the life for patients with ear, nose and throat conditions.
| Website: | www.intersectent.com |
| Main Phone: | +1 650 641-2100 |
| Address: | 1555 Adams Drive |
| State: | CA |
| City / Town: | Menlo Park |
| Country: | USA |
| Postal Code: | 94025 |
| Exchange: | NSD |
| Employees: | 275 |
| NAICS: | Surgical and Med |
| Last Price 40.75 | Change $ -0.25 | Change % -0.61 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask 42.10 | Ask Size 1,500.00 |
| Open 41.05 | High 41.25 | Low 39.85 | Prev Close 41.00 |
| Last Trade | Volume 210,389 | 52 Wk Hi 42.25 | 52 Wk Low 17.65 |
| Market Cap 1.2 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 29,804,937.00 | EPS (TTM) -0.56 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 5 | 34 |
| Number of Buys | 2 | 11 |
| Number of Sells | 3 | 23 |
| Net Activity | -500 | -62624 |
| Last 10 Buys | Shares |
|---|---|
| Kieran T. Gallahue | 1,000 |
| Kieran T. Gallahue | 1,000 |
| Cynthia L. Lucchese | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| James Stambaugh | 1,000 |
| James Stambaugh | 1,000 |
| James Stambaugh | 1,000 |
| Amy Wolbeck | 1,000 |
| Richard E. Kaufman | 1,000 |
| Lisa E. Earnhardt | 1,000 |
| Lisa E. Earnhardt | 1,000 |
| Richard E. Kaufman | 1,000 |
| Lisa E. Earnhardt | 1,000 |
| Frederic H. Moll | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 26 | 26 | 37 | 26 |
| Low Target Price Estimate | 21 | 21 | 20 | 21 |
| Mean Target Price Estimate | 23.8 | 23.8 | 25.83 | 23.4 |
| Standard Deviation | 1.92 | 1.92 | 5.85 | 2.3 |
| Date of Most Recent Estimate | 08/12/16 | 08/03/16 | 07/19/16 | 08/17/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 48 | 2016-08-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-05 |
| 8-K | Report of unscheduled material events or corporate changes. | 9 | 2016-08-02 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-19 |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2016-07-18 |
| SC 13G/A | Amendment to the SC 13G filing | 1 | 2016-07-12 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-29 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2016-06-29 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-14 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-06-07 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
